Skip to main navigation
Skip to search
Skip to main content
UNIC | Research Portal Home
Home
Profiles
Research units
Research output
Projects
Search by expertise, name or affiliation
Current therapies for chronic hepatitis B virus infection
Peter Karayiannis
Medical School
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Current therapies for chronic hepatitis B virus infection'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chronic Hepatitis B Virus Infection
100%
Current Therapies
100%
Interferon-α (IFN-α)
33%
Hepatic Decompensation
33%
Drug Resistance
33%
Cirrhosis
33%
Lamivudine
33%
Hepatocellular Carcinoma
33%
Patient Management
33%
Immunomodulator
33%
Therapeutic Intervention
33%
Treatment Perspectives
33%
Adefovir Dipivoxil
33%
Nucleos(t)ide Analogues
33%
Gilead
33%
Hepatitis B Virus
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Hepatitis B
100%
Lamivudine
66%
Adefovir Dipivoxil
66%
Hepatitis B Virus
33%
Interferon
33%
Immunomodulating Agent
33%
Liver Cell Carcinoma
33%
Liver Cirrhosis
33%
Decompensated Liver Cirrhosis
33%
Drug Resistance
33%